Fairvalue-Calculator Fairvalue-Calculator
EN DE

Anti-Microbial Savior BioteQ Co (6864) Fair Value & Analysis

Healthcare · TW · Market cap 1.9B TWD

Price47.65 TWD
Fair Value40.59 TWD
Upside-14.8%
Quality95/100
Evidence: Low Range 30.44 TWD – 50.74 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Anti-Microbial Savior BioteQ Co (6864) currently trades at 47.65 TWD, while our model-based Fair Value estimate is 40.59 TWD — implying the stock looks roughly 14.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Anti-Microbial Savior BioteQ Co., Ltd. focuses on the research and development of pharmaceutical drug products in Taiwan. It develops technology patenting of medical fungi. The company also provides MEDIACE, an antibacterial Ingredient containing skin-friendly materials and medicinal fungal extracts. In addition, it provides customized functional face masks. The company was founded in 2018 and is headquartered in Kaohsiung, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Anti-Microbial Savior BioteQ Co (6864) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 40.59 TWD versus a price of 47.65 TWD — about −15% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6864?
Our 21-model fair value for Anti-Microbial Savior BioteQ Co is 40.59 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 47.65 TWD.
What is the quality score of 6864?
Anti-Microbial Savior BioteQ Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.